The second multivariate survival model was applied to test the correlation between time from initial diagnosis to each subsequent relapse and BRCA1 mutation/promoter methylation status, assuming the independency of subsequent relapses and all originating from the primary tumor (illustrated in Fig. S1). This evidence concerns the gene BRCA1 and neoplasm.